Endologix, Inc. (Endologix) is engaged in developing, manufacturing, marketing, and selling medical devices for the treatment of aortic disorders. Endologix products are intended for the treatment of abdominal aortic aneurysms (AAA). The Company’s AAA products are built on one of two platforms: minimally-invasive endovascular repair (EVAR) or endovascular sealing (EVAS), Endologix’s solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR portfolio includes products, such as Endologix AFX Endovascular AAA System (AFX), VELA Proximal Endograft (VELA) and Endologix Intuitrak Endovascular AAA System (Intuitrak). The EVAS product is the Nellix Endovascular Aneurysm Sealing System (Nellix EVAS System).